A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy

[1]  A. Sood,et al.  A framework for a personalized surgical approach to ovarian cancer , 2015, Nature Reviews Clinical Oncology.

[2]  Jeong-Won Lee,et al.  Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification , 2015, Obstetrics & gynecology science.

[3]  G. Scambia,et al.  Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience. , 2013, Gynecologic oncology.

[4]  F. Ghezzi,et al.  A multicentric trial (Olympia-MITO 13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer. , 2013, American journal of obstetrics and gynecology.

[5]  B. Glimelius,et al.  Adjuvant chemotherapy , 2013, EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.].

[6]  J. Moon,et al.  Prognostic value of serum CA-125 in patients with advanced epithelial ovarian cancer followed by complete remission after adjuvant chemotherapy , 2013, Obstetrics & gynecology science.

[7]  S. Grénman,et al.  FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread. , 2012, Gynecologic oncology.

[8]  A. Bryant,et al.  Optimal primary surgical treatment for advanced epithelial ovarian cancer. , 2011, The Cochrane database of systematic reviews.

[9]  Jacobus Pfisterer,et al.  Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials , 2009, Cancer.

[10]  G. Scambia,et al.  Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma. , 2008, American journal of obstetrics and gynecology.

[11]  R. Rouzier,et al.  External Validation of a Laparoscopic-Based Score to Evaluate Resectability of Advanced Ovarian Cancers : Clues for a Simplified Score , 2008 .

[12]  R. Rouzier,et al.  External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score. , 2008, Gynecologic oncology.

[13]  A. Loft,et al.  Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography--a prospective study. , 2008, Gynecologic oncology.

[14]  B. Karlan,et al.  Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  G. Scambia,et al.  A Laparoscopy-Based Score To Predict Surgical Outcome in Patients With Advanced Ovarian Carcinoma: A Pilot Study , 2006, Annals of Surgical Oncology.

[16]  P. Vasey,et al.  Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  G. Bifulco,et al.  Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study. , 2005, Gynecologic oncology.

[18]  Hedvig Hricak,et al.  Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. , 2005, Gynecologic oncology.

[19]  K. Brandt,et al.  The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma , 2004, Cancer.

[20]  M. Gore,et al.  Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancer , 2003, International Journal of Gynecologic Cancer.

[21]  E. Venkatraman,et al.  The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma. , 2000, Gynecologic oncology.

[22]  He-jing Wang,et al.  Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. , 1998, Gynecologic oncology.

[23]  Goldie Jh,et al.  A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. , 1979 .

[24]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[25]  D. Chi,et al.  Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment. , 2011, Gynecologic oncology.

[26]  J. Dungan,et al.  Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer , 2011 .

[27]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[28]  J H Goldie,et al.  A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. , 1979, Cancer treatment reports.